FDA Presses Clinical Hold Button For BioNTech’s Partner Late-Stage Trial Of Investigational Lung Cancer Treatment – BioNTech (NASDAQ:BNTX)
BioNTech SE BNTX has been notified by its partner, OncoC4 Inc., that the FDA has imposed a partial clinical hold on its Phase 3 PRESERVE-003 trial. The open-label, randomized study…
